GV
Therapeutic Areas
Istesso Pipeline
| Drug | Indication | Phase |
|---|---|---|
| leramistat | Chronic disease with tissue damage (specific indication not disclosed) | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| leramistat | Chronic disease with tissue damage (specific indication not disclosed) | Phase 2 |